$278.11-1.17 (-0.42%)
Ecolab Inc.
Ecolab Inc. in the Basic Materials sector is trading at $278.11 with a market capitalization of $77.4B. Wall Street consensus targets $324.95 (21 analysts), implying a +16.8% move over the next 12 months. The stock is currently 10% below its 52-week high of $309.27, remaining 2.2% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $4.42B↑ | $4.07B↓ | $4.20B↑ | $4.17B↑ | $4.03B |
| Gross Profit | $1.95B↑ | $1.77B↓ | $1.85B↓ | $1.87B↑ | $1.80B |
| Operating Income | $804.30M↑ | $668.40M↓ | $786.60M | $786.40M↑ | $734.70M |
| Net Income | $534.90M↑ | $432.60M↓ | $563.90M↓ | $585.00M↑ | $524.20M |
Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through four segments: Global Water, Global Institutional & Specialty, Global Pest Elimination, and Gl...

Ecolab has lagged behind the Nasdaq Composite over the past year, and analysts remain reasonably bullish about the stock’s growth potential.

Ecolab (ECL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

The largest holding in his portfolio also helps fund the Gates Foundation.

Ecolab has underperformed the broader market, while analysts remain moderately optimistic, supported by earnings growth, raised guidance, and potential upside.
Ecolab's (ECL) projected commodity cost increase of high-single-digit percentage in H2 is manageable
Academic risk and quality models computed from ECL's own filings and price history, not from analyst opinion.
Mixed: 5 of 9 fundamental-health tests pass, so profitability and balance-sheet trends disagree.
Altman Z above the 2.99 safe threshold, so the model puts bankruptcy risk in its lowest band.
Beneish M below the -1.78 flag threshold, so the earnings-manipulation model finds nothing unusual in the accruals and margin trends.
Share of earnings coming from accruals rather than cash. Higher values historically precede weaker future returns.
GARCH(1,1) 30-day annualised forecast, level with the current 21.9% reading.
Fama-French 5-factor market beta. The five factors explain 38% of this stock's return variance; the rest is idiosyncratic.
The stock’s own historical valuation anchor, which is a fairer comparison than a sector average for a company with a persistent premium or discount.
Model inputs as of 2026-09-08.